Stock listing

Assertio Holdings, Inc.

Selected listing: ASRT · NASDAQ · USD · US

Assertio Holdings, Inc. (NASDAQ:ASRT), Health Technology. Latest release Jul 9, 2026: Astellas to Spotlight New Research for Geographic Atrophy at ASRS 2026…

ASRT:NASDAQUSDUSUpdated October 4, 2026

Ticker: NASDAQ:ASRT
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: NASDAQ
Currency: USD

About Assertio Holdings, Inc.

The company operates in the pharmaceutical sector, focusing on developing and commercializing innovative treatments. Assertio is dedicated to improving patient outcomes through its specialized product offerings.

Latest news from Assertio Holdings, Inc.

Astellas to Spotlight New Research for Geographic Atrophy at ASRS 2026 Annual Meeting

July 9, 2026

Assertio Announces Completion of Merger with Zydus Lifesciences and Fundamental Change and Make-Whole Fundamental Change Relating to its Outstanding 6.50% Convertible Senior Notes due 2027

June 16, 2026

Assertio to Be Acquired by Zydus Worldwide DMCC for $23.50 Per Share in Cash

May 13, 2026

Assertio and Garda Mutually Agree to Delay Launch of Tender Offer

May 8, 2026

Assertio and Garda Mutually Agree to Postpone Commencement of Tender Offer

May 5, 2026

All Assertio Holdings, Inc. news →

Events

Replays

Assertio Holdings, Inc. (ASRT) Q4 2025 Earnings Call
Mon, Mar 16, 2026 · 04:30 PM ET
Watch
Assertio Holdings, Inc. (ASRT) Q3 2025 Earnings Call
Mon, Nov 10, 2025 · 04:30 PM ET
Watch
Assertio Holdings, Inc. (ASRT) Q2 2025 Earnings Call
Mon, Aug 11, 2025 · 04:30 PM ET
Watch